CPRIT Fellowship

CPRIT Fellowship - Financial Assistance - Fellowship - cprit Fellowship

Innovation for Cancer Prevention Research

We are not currently accepting applications from doctoral students and post-doctoral candidates for the CPRIT Fellowship Program. A status update will be posted in early December.

Please contact Patricia Dolan Mullen, DrPH, 713-500-9658, for further information.

 

Welcome to the CPRIT-UT Health – Fellowship in Innovation for Cancer Prevention Research (ICPR) – UT Health’s training program for pre- and post-doctoral fellowships in cancer prevention and control. This program goes beyond being a quality cancer education and career development program to focus on helping those seeking a career in cancer prevention and control research to learn to ask the important research questions, apply cutting edge methods, and move the field of cancer forward in big – not baby steps.

About CPRIT

The program is generously funded by the UTHealth Innovation in Cancer Prevention Research Training Program (Cancer Prevention and Research Institute of Texas grant #RP140103). The CPRIT program was created in 2007 as part of a voter-approved constitutional amendment authorizing the state to issue $3 billion in bonds to fund groundbreaking cancer research and prevention programs and services in Texas.

You can find out more about CPRIT at their website:

http://www.cprit.state.tx.us/

Predoctoral Cancer Education and Career Development Program

What the Program Offers

Full time Doctoral fellows (who may be on international visas) receive:

  • Training and coaching in innovative thinking by the author of four books on innovation, UTHealth’s Vice-President for Innovation, Dr. Roberta Ness
  • Excellent mentoring in a rich research environment with the stimulation of a complementary mentor
  • $28,000 for full-time effort toward a rigorous academic program
  • Full benefits and paid tuition (up to $6,000 based on in-state status that comes with the fellowship) for doctoral studies and approved short courses. Also, books, software, $1000 travel to national meetings, cubicle space, and a desktop or laptop computer
  • Writing consultation
  • Ongoing support and feedback in an integrative research seminar for fellows, led by the Program directors; sessions focus on application of innovative thinking to work in progress, dissertation and grant applications, ethics cases, and provocative journal articles, and career development writing and presentation skills
  • Coursework and on-line training in the responsible conduct of research

Affiliate fellows with salary support from employment related to cancer receive the training and coaching, mentoring, tuition and books, travel, computer, writing consultation, and ongoing support and feedback in the integrative seminar. 

Note:  Appointments are guaranteed for one year.  We are currently applying for a 5-year renewal, with the decision to be announced November 2014.

 

CURRENT FELLOWS

Muhammad "Tuan" Amith

Current Institution:

School of Biomedical Informatics, University of Texas Health Science Center, Houston, TX

Previous Institutions:

University of Houston-Clear Lake, Houston, TX, MS in Software Engineering

University of Houston, Victoria, TX, BS in Computer Science (with honors)

Select Publications

  • Myneni S, Amith M, Geng Y, Tao C. Towards an Ontology-driven Framework to Enable Development of Personalized mHealth Solutions for Cancer Survivors’ Engagement in Healthy Living. MedInfo 2015. (Accepted.)
  • Amith M, Gong Y, Cunningham R, Boom J, Tao C. Developing VISO: Vaccine Information Statement Ontology for patient education. Journal of Biomedical Semantics. 2015 May 1;6(1):23.
  • Amith M, Tao C. A Prototype Mobile Virtual Assistant for Semantic-Based Vaccine Information Retrieval. In: Zheng X, Zeng D, Chen H, Zhang Y, Xing C, Neill D, editors. Smart Health [Internet]. Springer International Publishing; 2014. p. 200–5. 
  • Amith M, Loubser PG, Chapman J, Zoker KC, Rabelo Ferreira FER. Optimization of an EHR Mobile Application Using the UFuRT Conceptual Framework. AMIA Annu Symp Proc. 2012 Nov 3;2012:209–17.

Andrew Aschenbrenner

Andrew Aschenbrenner Photo

Current Institution:

University of Texas School of Public Health, Houston, TX; PhD in Biostatistics

Previous Institutions:

University of California, Irvine, Irvine, CA; BS in Mathematics

CPRIT Project Title

Multivariate analysis in RNA-Seq gene expression data

 

Jose Franck Diaz Vasquez

Jose Franck Vasquez Diaz Photo

Current Institutions

The University of Texas School of Biomedical Informatics, Houston, TX; PhD in Biomedical Informatics

Previous Institutions

  • Ecole Superieure d’Ingenieurs de Luminy (ESIL - Polytec’ Marseille). Marseille, France; Diplome d’ingenieur (MS+BS) in Biomedical Engineering
  • International Exchange at Texas A&M, College Station, TX; Non-degree program in Biomedical Engineering
  • Santo Domingo Institute of Technology, Santo Domingo, Dominican Republic; BS in Mechanical Engineering

CPRIT Project Title

Systematic data quality assessment for the reliable reuse of clinical data in research

Select Publications

  • Jose-Franck Diaz-Garelli, MS, Elmer V. Bernstam, MD, MSE, Mohammad H. Rahbar PhD, Todd Johnson, PhD “Rediscovering drug side effects: the impact of analytical assumptions on the detection of associations in EHR data” at AMIA CRI 2015, San Francisco, CA. Spring 2015. - Under Review
  • Franck Diaz-Garelli MS, Muhammad Walji PhD, Amy Franklin PhD, Jiajie Zhang PhD “Is drug-drug interaction alert overriding dependent on temporal separation?” at AMIA symposium 2013, Washington DC. Fall 2013.

Jingcheng Du

Jingcheng Du Photo

Current Institutions

The University of Texas School of Biomedical Informatics, Houston, TX; PhD in Medical Informatics

Previous Institutions

  • School of Electronic, Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, China; Ph.D. student, Electrical Engineering, August 2013 – June 2014
  • School of Mechano-Electronic Engineering, Xidian University, Shaanxi, China; BS in Mechanical Engineering

Select Publications

  • Du J, Cai Y, Chen Y, Tao C, Adverse Event Analysis for Trivalent Influenza Vaccine Based On MedDRA Terminology Using VAERS Data, International Workshop on Vaccine and Drug Ontology Studies (VDOS) -in conjunction with the International Conference on Biomedical Ontology (ICBO) 2015, Lisbon, July, 2015
  • Tao C, Du J, Cai Y and Chen Y, Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data, 15th World Congress on Health and Biomedical Informatics (MEDINFO 2015)
  • Zheng W, Du J, Tang J and Tao C, GSO: A Semantic Web Ontology to Capture 3D Genome Structure, International Workshop on Semantic Web Applications and Tools for Life Sciences (SWAT4LS), 2014, Berlin, Germany
  • Tian H, Liu J, Kang X, Wei D, Zhang C, Du J, Yang B, Chen X, and Yang C. "Biotic and abiotic molecule dopants determining the electrochemical performance, stability and fibroblast behavior of conducting polymer for tissue interface." RSC Advances 4, no. 88 (2014): 47461-47471.
  • Tian H, Liu J, Wei D, Kang X, Zhang C, Du J, Yang B. "Graphene oxide doped conducting polymer nanocomposite film for electrode-tissue interface." Biomaterials 35, no. 7 (2014): 2120-2129.


Krit Ritthipichai

Krit Ritthipichai PhotoCurrent Institutions

The University of Texas Graduate School of Biomedical Sciences, Houston, TX; PhD in Immunology

Previous Institutions

  • University of Maryland, College Park, MD; MS in Veterinary Medical Sciences
  • Kasetsart University, Bangkok, Thailand; DVM

CPRIT Project Title

Uncovering the role of RNA-binding protein with multiple splicing in tumor infiltrating lymphocytes

Select Publications

  • Sim GC, Chacon J, Haymaker C, Ritthipichai K, Singh M, Hwu P, Radvanyi L. 2014. Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development. BioDrugs:1-17.


Zhiguo Yu

Zhiguo Yu Photo

Current Institutions

The University of Texas School of Biomedical Informatics, Houston, TX; PhD in Biomedical Informatics

Previous Institutions

  • University of Kentucky, Lexington, KY; MS in Electrical and Computer Engineering
  • Beijing Institute of Technology, Beijing, China; BS in Electronic Engineering and Information Science

CPRIT Project Title

Application of topic models in personalized cancer therapy

Postdoctoral Program

What the Program Offers

Full time Postdoctoral fellows (who may be on international visas) receive:

  • Training and coaching in innovative thinking by the author of four books on innovation, UTHealth’s Vice-President for Innovation, Dr. Roberta Ness
  • Excellent mentoring in a rich research environment with the stimulation of a complementary mentor
  • $50,000 for full-time effort
  • Full benefits and paid tuition (up to $6,000 based on in-state status that comes with the fellowship) coursework, including approved short courses. Also, books, software, $2000 travel to national meetings, shared office space, and a desktop or laptop computer
  • Writing consultation
  • Ongoing support and feedback in an integrative research seminar for fellows, led by the Program directors; sessions focus on application of innovative thinking to work in progress, dissertation and grant applications, ethics cases, and provocative journal articles, and career development writing and presentation skills
  • Coursework and on-line training in the responsible conduct of research

Affiliate fellows with salary support from employment related to cancer receive the training and coaching, mentoring, tuition and books, travel, computer, writing consultation, and ongoing support and feedback in the integrative seminar. 

Note:  Appointments are guaranteed for one year.  We are currently applying for a 5-year renewal, with the decision to be announced November 2014. 

CURRENT FELLOWS

Jingjing Jiao

Jingjing Jiao PhotoCurrent Institutions

MD Anderson Cancer Center, Department of Molecular and Cellular Oncology, Houston, TX; Postdoctoral fellow

Previous Institutions

Mount Sinai School of Medicine, New York, NY; PhD

CPRIT Project Title

Etiology and molecular characteristic of high prevalence of HCC and underlying liver disease in Hispanics in South Texas

 

Hong Kang

Hong Kang Photo

Current Institutions

The University of Texas School of Biomedical Informatics, Houston, TX; Postdoctoral Fellow

Previous Institutions

Tongji University, Shanghai, China; PhD in Biomedical Engineering

Tongji University, Shanghai, China; MS in Biomedical Engineering

Zhejiang University, Hangzhou, China; BS in Electronic and Communication Engineering

CPRIT Project Title

E-Reporting: Improving Patient Safety. The importance of improving data quality in voluntary medical incident reporting systems

Select Publications

  • Kang H, Tang K, Yang L, et al. 2015. Integrating clinical indexes into four-diagnostic information contributes to the Traditional Chinese Medicine (TCM) syndrome diagnosis of Chronic Hepatitis B. Scientific Reports. 5: 9395.
  • Kang H, Tang K, Liu Q, et al. 2013. HIM-herbal ingredients in-vivo metabolism database. J Cheminform. 5(1): 28.
  • Kang H, Sheng Z, Zhu R, et al. 2012. Virtual drug screen schema based on multiview similarity integration and ranking aggregation. J Chem Inf Model. 52(3): 834-843.
  • Sheng Z*, Kang H*, Dai T, et al. 2010. Complementary study of structure features and gene profile features for chemical compounds. Acta Chimica Sinica. 68: 2395. *Contributed equally.

Sara Prijic

Sara Prijic Photo

Current Institutions

The University of Texas Medical School, Department of Integrative Biology and Pharmacology, Houston, TX; Postdoctoral fellow

Previous Institutions

University of Ljubljana Faculty of Medicine, Ljubljana, Slovenia; PhD in Basic Medical Sciences

University of Ljubljana Veterinary Faculty, Ljubljana, Slovenia; DVM

CPRIT Project Title

Aberrant cell cholesterol homeostasis in metastatic breast cancer

Arzu Ulu

Arzu Ulu Photo

Current Institutions

The University of Texas Medical School, Department of Integrative Biology and Pharmacology, Houston, TX; Postdoctoral fellow

Previous Institutions

University of California Davis, Davis, CA, PhD in Pharmacology and Toxicology

Select Publications

  • Song EH, Oh W, Ulu A, Carr HS, Zuo Y, Frost JA. 2015.  Acetylation of the RhoA GEF Net1A controls its subcellular localization and activity. J Cell Sci. 128(5):913-22.
  • Ulu A, Lee KS, Miyabe C, Yang J, Hammock BG, Dong H, Hammock BD. 2014. An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II dependent hypertension. J Cardiovasc Pharmacol, 64(1):87-89.
  • Ulu A, Harris TR, Morisseau C, Miyabe C, Inoue H, Schuster G, Dong H, Liu JY, Weiss RH, Chiamvimonvat N, Imig JD, Hammock BD. 2013. Anti-inflammatory effects of omega-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II dependent hypertension. J Cardiovasc Pharmacol.; 62(3):285-97.
  • Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu JY, Stephen Lee KS, Wettersten HI, Ulu A, Hu X, Tam S, Hwang SH, Ingham ES, Kieran MW, Weiss RH, Ferrara KW, Hammock BD. 2013. Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A.;110(16):6530-5.
  • Ulu A, Appt SE, Morisseau C, Hwang SH, Rose TE, Jones PD, Dong H, Miyabe C, Lango J, Yang J, Tsai HJ, Fortenbach C, Adams MR, Hammock BD. 2012.  Pharmacokinetics, and in vivo potency of urea soluble epoxide hydrolase inhibitors in Cynomolgus monkeys. Br J Pharmacol.;165 (5):1401-12.

Take the Innovation thinking course by the head of the program, Roberta B. Ness, M.D., M.P.H., who literally wrote the book on innovation: Innovation Generation: How to Produce Creative and Useful Scientific Ideas  as well as Genius Unmasked and Creativity in the Sciences: A Workbook Companion to Innovation Generation. Her newest book, The Creativity Crisis: Reinventing Science to Unleash Possibility, was released in December of 2014.

Dr. Ness' online course on innovation will launch on July 27, 2015. Enroll in it now!

Creativity Crisis Book Cover

Click below to see the TedXHouston talk, "Innovative thinking: Can you be taught?" with Roberta B. Ness, MD, MPH